APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis (TB) Detection

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.

Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.

Selected research

Market Outlook & Growth Opportunities

Global Tuberculosis (TB) Detection Market Outlook and Growth Opportunities 2026

28 December 2025199 pages

Choose your research edition.

Industry ResearchTuberculosis (TB) Detection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis (TB) Detection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Tuberculosis (TB) Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis (TB) Detection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis (TB) Detection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.

Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.

In Southeast Asia, Tuberculosis (TB) Detection key players include Danaher, Roche, Thermal Fisher, Abbott, etc.

Read the full market overview

Indonesia is the largest market, with a share over 20%, followed by Philippines, and Myanmar, both have a share about 30 percent.

In terms of product, Bacterial Culture Test is the largest segment, with a share about 50%. And in terms of application, the largest application is Hospital, followed by Clinic, Research Institution, etc.

This report provides an overview of the global Tuberculosis (TB) Detection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tuberculosis (TB) Detection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tuberculosis (TB) Detection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Tuberculosis (TB) Detection market.

Tuberculosis (TB) Detection Segment by Company

Danaher

Roche

Thermal Fisher

Abbott

Oxford Immunotec International

Qiagen

Hologic

Hain Lifescience

Epistem

Creative Diagnostics

Tuberculosis (TB) Detection Segment by Type

Bacterial Culture Test

Tuberculin Test

Rapid Molecular Diagnosis

Other

Tuberculosis (TB) Detection Segment by Application

Hospital

Clinic

Research Institution

Other

Tuberculosis (TB) Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tuberculosis (TB) Detection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Tuberculosis (TB) Detection key companies, revenue, market share, and recent developments.

3. To split the Tuberculosis (TB) Detection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Tuberculosis (TB) Detection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tuberculosis (TB) Detection significant trends, drivers, influence factors in global and regions.

6. To analyze Tuberculosis (TB) Detection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculosis (TB) Detection industry.

Chapter 3: Detailed analysis of Tuberculosis (TB) Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Tuberculosis (TB) Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Tuberculosis (TB) Detection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tuberculosis (TB) Detection Industry Trends Table 2. Tuberculosis (TB) Detection Industry Drivers Table 3. Tuberculosis (TB) Detection Industry Opportunities and Challenges Table 4. Tuberculosis (TB) Detection Industry Restraints Table 5. Global Tuberculosis (TB) Detection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tuberculosis (TB) Detection Revenue Share by Company (2021-2026) Table 7. Global Tuberculosis (TB) Detection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Tuberculosis (TB) Detection Key Company Manufacturing Base & Headquarters Table 9. Global Tuberculosis (TB) Detection Company, Product Type & Application Table 10. Global Tuberculosis (TB) Detection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Tuberculosis (TB) Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Bacterial Culture Test Table 15. Significant Companies of Tuberculin Test Table 16. Significant Companies of Rapid Molecular Diagnosis Table 17. Significant Companies of Other Table 18. Global Tuberculosis (TB) Detection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Tuberculosis (TB) Detection Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Tuberculosis (TB) Detection Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Tuberculosis (TB) Detection Sales Value Share by Type (2021-2026) Table 22. Global Tuberculosis (TB) Detection Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Clinic Table 25. Significant Companies of Research Institution Table 26. Significant Companies of Other Table 27. Global Tuberculosis (TB) Detection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Tuberculosis (TB) Detection Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Tuberculosis (TB) Detection Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Tuberculosis (TB) Detection Sales Value Share by Application (2021-2026) Table 31. Global Tuberculosis (TB) Detection Sales Value Share by Application (2027-2032) Table 32. Global Tuberculosis (TB) Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Tuberculosis (TB) Detection Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Tuberculosis (TB) Detection Sales Value Share by Region (2021-2026) Table 35. Global Tuberculosis (TB) Detection Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Tuberculosis (TB) Detection Sales Value Share by Region (2027-2032) Table 37. Global Tuberculosis (TB) Detection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Tuberculosis (TB) Detection Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Tuberculosis (TB) Detection Sales Value Market Share by Country (2021-2026) Table 40. Global Tuberculosis (TB) Detection Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Tuberculosis (TB) Detection Sales Value Market Share by Country (2027-2032) Table 42. Danaher Company Information Table 43. Danaher Business Overview Table 44. Danaher Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Danaher Tuberculosis (TB) Detection Product Portfolio Table 46. Danaher Recent Development Table 47. Roche Company Information Table 48. Roche Business Overview Table 49. Roche Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Roche Tuberculosis (TB) Detection Product Portfolio Table 51. Roche Recent Development Table 52. Thermal Fisher Company Information Table 53. Thermal Fisher Business Overview Table 54. Thermal Fisher Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Thermal Fisher Tuberculosis (TB) Detection Product Portfolio Table 56. Thermal Fisher Recent Development Table 57. Abbott Company Information Table 58. Abbott Business Overview Table 59. Abbott Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Abbott Tuberculosis (TB) Detection Product Portfolio Table 61. Abbott Recent Development Table 62. Oxford Immunotec International Company Information Table 63. Oxford Immunotec International Business Overview Table 64. Oxford Immunotec International Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Oxford Immunotec International Tuberculosis (TB) Detection Product Portfolio Table 66. Oxford Immunotec International Recent Development Table 67. Qiagen Company Information Table 68. Qiagen Business Overview Table 69. Qiagen Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Qiagen Tuberculosis (TB) Detection Product Portfolio Table 71. Qiagen Recent Development Table 72. Hologic Company Information Table 73. Hologic Business Overview Table 74. Hologic Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hologic Tuberculosis (TB) Detection Product Portfolio Table 76. Hologic Recent Development Table 77. Hain Lifescience Company Information Table 78. Hain Lifescience Business Overview Table 79. Hain Lifescience Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hain Lifescience Tuberculosis (TB) Detection Product Portfolio Table 81. Hain Lifescience Recent Development Table 82. Epistem Company Information Table 83. Epistem Business Overview Table 84. Epistem Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Epistem Tuberculosis (TB) Detection Product Portfolio Table 86. Epistem Recent Development Table 87. Creative Diagnostics Company Information Table 88. Creative Diagnostics Business Overview Table 89. Creative Diagnostics Tuberculosis (TB) Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Creative Diagnostics Tuberculosis (TB) Detection Product Portfolio Table 91. Creative Diagnostics Recent Development Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Tuberculosis (TB) Detection Product Image Figure 2. Global Tuberculosis (TB) Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis (TB) Detection Market Size (2021-2032) & (US$ Million) Figure 4. Global Tuberculosis (TB) Detection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Bacterial Culture Test Image Figure 8. Tuberculin Test Image Figure 9. Rapid Molecular Diagnosis Image Figure 10. Other Image Figure 11. Global Tuberculosis (TB) Detection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Tuberculosis (TB) Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Tuberculosis (TB) Detection Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Research Institution Image Figure 17. Other Image Figure 18. Global Tuberculosis (TB) Detection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Tuberculosis (TB) Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Tuberculosis (TB) Detection Sales Value Share by Application (2021-2032) Figure 21. Global Tuberculosis (TB) Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Tuberculosis (TB) Detection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Tuberculosis (TB) Detection Sales Value (2021-2032) & (US$ Million) Figure 24. North America Tuberculosis (TB) Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Tuberculosis (TB) Detection Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Tuberculosis (TB) Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Tuberculosis (TB) Detection Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Tuberculosis (TB) Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Tuberculosis (TB) Detection Sales Value (2021-2032) & (US$ Million) Figure 30. South America Tuberculosis (TB) Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Tuberculosis (TB) Detection Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Tuberculosis (TB) Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Bacterial Culture Test
  • Tuberculin Test
  • Rapid Molecular Diagnosis
  • Other
Applications
  • Hospital
  • Clinic
  • Research Institution
  • Other
Companies covered
  • Danaher
  • Roche
  • Thermal Fisher
  • Abbott
  • Oxford Immunotec International
  • Qiagen
  • Hologic
  • Hain Lifescience
  • Epistem
  • Creative Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tuberculosis (TB) Detection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tuberculosis (TB) Detection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Tuberculosis (TB) Detection Market Dynamics
  1. 2.1 Tuberculosis (TB) Detection Industry Trends
  2. 2.2 Tuberculosis (TB) Detection Industry Drivers
  3. 2.3 Tuberculosis (TB) Detection Industry Opportunities and Challenges
  4. 2.4 Tuberculosis (TB) Detection Industry Restraints
3 Tuberculosis (TB) Detection Market by Company
  1. 3.1 Global Tuberculosis (TB) Detection Company Revenue Ranking in 2025
  2. 3.2 Global Tuberculosis (TB) Detection Revenue by Company (2021-2026)
  3. 3.3 Global Tuberculosis (TB) Detection Company Ranking (2024-2026)
  4. 3.4 Global Tuberculosis (TB) Detection Company Manufacturing Base and Headquarters
  5. 3.5 Global Tuberculosis (TB) Detection Company Product Type and Application
  6. 3.6 Global Tuberculosis (TB) Detection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Tuberculosis (TB) Detection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Tuberculosis (TB) Detection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Tuberculosis (TB) Detection Market by Type
  1. 4.1 Tuberculosis (TB) Detection Type Introduction
  2. 4.1.1 Bacterial Culture Test
  3. 4.1.2 Tuberculin Test
  4. 4.1.3 Rapid Molecular Diagnosis
  5. 4.1.4 Other
  6. 4.2 Global Tuberculosis (TB) Detection Sales Value by Type
  7. 4.2.1 Global Tuberculosis (TB) Detection Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Tuberculosis (TB) Detection Sales Value by Type (2021-2032)
  9. 4.2.3 Global Tuberculosis (TB) Detection Sales Value Share by Type (2021-2032)
5 Tuberculosis (TB) Detection Market by Application
  1. 5.1 Tuberculosis (TB) Detection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Research Institution
  5. 5.1.4 Other
  6. 5.2 Global Tuberculosis (TB) Detection Sales Value by Application
  7. 5.2.1 Global Tuberculosis (TB) Detection Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tuberculosis (TB) Detection Sales Value by Application (2021-2032)
  9. 5.2.3 Global Tuberculosis (TB) Detection Sales Value Share by Application (2021-2032)
6 Tuberculosis (TB) Detection Regional Value Analysis
  1. 6.1 Global Tuberculosis (TB) Detection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tuberculosis (TB) Detection Sales Value by Region (2021-2032)
  3. 6.2.1 Global Tuberculosis (TB) Detection Sales Value by Region: 2021-2026
  4. 6.2.2 Global Tuberculosis (TB) Detection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tuberculosis (TB) Detection Sales Value (2021-2032)
  7. 6.3.2 North America Tuberculosis (TB) Detection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Tuberculosis (TB) Detection Sales Value (2021-2032)
  10. 6.4.2 Europe Tuberculosis (TB) Detection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Tuberculosis (TB) Detection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Tuberculosis (TB) Detection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Tuberculosis (TB) Detection Sales Value (2021-2032)
  16. 6.6.2 South America Tuberculosis (TB) Detection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Tuberculosis (TB) Detection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Tuberculosis (TB) Detection Sales Value Share by Country, 2025 VS 2032
7 Tuberculosis (TB) Detection Country-level Value Analysis
  1. 7.1 Global Tuberculosis (TB) Detection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tuberculosis (TB) Detection Sales Value by Country (2021-2032)
  3. 7.2.1 Global Tuberculosis (TB) Detection Sales Value by Country (2021-2026)
  4. 7.2.2 Global Tuberculosis (TB) Detection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Tuberculosis (TB) Detection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Tuberculosis (TB) Detection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Tuberculosis (TB) Detection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Danaher
  2. 8.1.1 Danaher Company Information
  3. 8.1.2 Danaher Business Overview
  4. 8.1.3 Danaher Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Danaher Tuberculosis (TB) Detection Product Portfolio
  6. 8.1.5 Danaher Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Tuberculosis (TB) Detection Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Thermal Fisher
  14. 8.3.1 Thermal Fisher Company Information
  15. 8.3.2 Thermal Fisher Business Overview
  16. 8.3.3 Thermal Fisher Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermal Fisher Tuberculosis (TB) Detection Product Portfolio
  18. 8.3.5 Thermal Fisher Recent Developments
  19. 8.4 Abbott
  20. 8.4.1 Abbott Company Information
  21. 8.4.2 Abbott Business Overview
  22. 8.4.3 Abbott Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Tuberculosis (TB) Detection Product Portfolio
  24. 8.4.5 Abbott Recent Developments
  25. 8.5 Oxford Immunotec International
  26. 8.5.1 Oxford Immunotec International Company Information
  27. 8.5.2 Oxford Immunotec International Business Overview
  28. 8.5.3 Oxford Immunotec International Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Oxford Immunotec International Tuberculosis (TB) Detection Product Portfolio
  30. 8.5.5 Oxford Immunotec International Recent Developments
  31. 8.6 Qiagen
  32. 8.6.1 Qiagen Company Information
  33. 8.6.2 Qiagen Business Overview
  34. 8.6.3 Qiagen Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qiagen Tuberculosis (TB) Detection Product Portfolio
  36. 8.6.5 Qiagen Recent Developments
  37. 8.7 Hologic
  38. 8.7.1 Hologic Company Information
  39. 8.7.2 Hologic Business Overview
  40. 8.7.3 Hologic Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hologic Tuberculosis (TB) Detection Product Portfolio
  42. 8.7.5 Hologic Recent Developments
  43. 8.8 Hain Lifescience
  44. 8.8.1 Hain Lifescience Company Information
  45. 8.8.2 Hain Lifescience Business Overview
  46. 8.8.3 Hain Lifescience Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hain Lifescience Tuberculosis (TB) Detection Product Portfolio
  48. 8.8.5 Hain Lifescience Recent Developments
  49. 8.9 Epistem
  50. 8.9.1 Epistem Company Information
  51. 8.9.2 Epistem Business Overview
  52. 8.9.3 Epistem Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Epistem Tuberculosis (TB) Detection Product Portfolio
  54. 8.9.5 Epistem Recent Developments
  55. 8.10 Creative Diagnostics
  56. 8.10.1 Creative Diagnostics Company Information
  57. 8.10.2 Creative Diagnostics Business Overview
  58. 8.10.3 Creative Diagnostics Tuberculosis (TB) Detection Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Creative Diagnostics Tuberculosis (TB) Detection Product Portfolio
  60. 8.10.5 Creative Diagnostics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst